Oxaliplatin and Its Effects on Arthritis
Author Information
Author(s): Östberg Therese, Wähämaa Heidi, Palmblad Karin, Ito Norimasa, Stridh Pernilla, Shoshan Maria, Lotze Michael T, Harris Helena Erlandsson, Andersson Ulf
Primary Institution: Karolinska Institutet/Karolinska University Hospital
Hypothesis
Does nuclear sequestration of HMGB1 prevent its release and benefit synovitis treatment?
Conclusion
Oxaliplatin therapy can reduce inflammation in arthritis by retaining HMGB1 in the nucleus.
Supporting Evidence
- Oxaliplatin treatment reduced the incidence and severity of arthritis in mice.
- Oxaliplatin showed a biphasic response pattern in HMGB1 retention.
- Clinical relapse occurred when HMGB1 was released extracellularly.
Takeaway
Oxaliplatin helps treat arthritis by keeping a protein called HMGB1 inside cells, which stops it from causing inflammation.
Methodology
The study evaluated oxaliplatin's effects on collagen type II-induced arthritis in mice through clinical scoring and immunostaining.
Limitations
The study was conducted on mice, which may not fully represent human arthritis.
Participant Demographics
DBA/1 mice, 18–22 g
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website